To gain a better understanding of the role of ANXA1 in the pathophysiology of T2D, we used a murine model of HFD-induced insulin resistance, hepatic steatosis and renal dysfunction (diabetic nephropathy). This evidence concerns the gene ANXA1 and fatty liver disease.